Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SANDOZ

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 23
  • 0 comments

FDA approve HYDROXYCHLOROQUINE SULFATE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 31
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

XGEN PHARMS

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 31
  • 0 comments

FDA approve NELARABINE

Comment Full text

CIPLA

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 27
  • 0 comments

FDA approve HYDROCORTISONE SODIUM SUCCINATE

Comment Full text

BIONPHARMA

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 29
  • 0 comments

FDA approve IVABRADINE HYDROCHLORIDE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 09, 2024, 04:15 UTC
  • 33
  • 0 comments

FDA approve EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Sept. 09, 2024, 04:15 UTC
  • 29
  • 0 comments

FDA approve THEOPHYLLINE

Comment Full text

PACIRA PHARMS INC

  • FDA Approval
  • Sept. 06, 2024, 19:08 UTC
  • 32
  • 0 comments

FDA approve TRIAMCINOLONE ACETONIDE

Comment Full text

USWM

  • FDA Approval
  • Sept. 06, 2024, 19:08 UTC
  • 31
  • 0 comments

FDA approve LOFEXIDINE HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 30
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text
  • Previous
  • 267
  • 268
  • 269
  • 270
  • 271
  • Next

Search

News categories

  • Technical Exchange News(9977)
  • Event(412)
  • SEC News(168776)
  • FDA Approval(9377)
  • Company Report(721)
  • Business News(112462)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin